The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
>95% by SDS-PAGE . ab169713 was purified by Ion-exchange chromatography.
Concentration information loading...
Preparation and Storage
Stability and Storage
Shipped at 4°C. Store at -20ºC.
Constituents: 90% PBS, 10% Trehalose
Reconstitute with sterile phosphate-buffered saline containing at least 0.1% carrier protein. Store reconstituted protein in working aliquots with a carrier protein at -20°C. Avoid repeated freeze/thaw cycles.
ApoL related ligand TALL 1
B cell Activating Factor
B lymphocyte stimulator
Dendritic cell derived TNF like molecule
Dendritic cell-derived TNF-like molecule
TNF and APOL related leukocyte expressed ligand 1
TNF homolog that activates apoptosis
TNF homolog that activates apoptosis NKFB and JNK.
TNF- and APOL-related leukocyte expressed ligand 1
Tumor necrosis factor (ligand) superfamily member 13b
Tumor necrosis factor ligand 7A
Tumor necrosis factor ligand superfamily member 13b
Tumor necrosis factor ligand superfamily member 20
Tumor necrosis factor like protein ZTNF4
Tumor necrosis factor superfamily member 13B
Cytokine that binds to TNFRSF13B/TACI and TNFRSF17/BCMA. TNFSF13/APRIL binds to the same 2 receptors. Together, they form a 2 ligands -2 receptors pathway involved in the stimulation of B-and T-cell function and the regulation of humoral immunity. A third B-cell specific BAFF-receptor (BAFFR/BR3) promotes the survival of mature B-cells and the B-cell response.
Abundantly expressed in peripheral blood Leukocytes and is specifically expressed in monocytes and macrophages. Also found in the spleen, lymph node, bone marrow, T-cells and dendritic cells. A lower expression seen in placenta, heart, lung, fetal liver, thymus, and pancreas.
Belongs to the tumor necrosis factor family.
The soluble form derives from the membrane form by proteolytic processing. N-glycosylated.